Explainer · US
Supplements and prescription medicines: which interactions are real, from St. John's wort to ginkgo
The UAE's medicines regulator has warned about mixing supplements with prescription medicines. What the evidence shows for St. John's wort, ginkgo, vitamin K, calcium, iron and biotin, and when to ask a pharmacist first.
Review type: research summary. This page summarises published research and product labels, cited below.
On November 17, 2026 the Emirates Drug Establishment (EDE), the federal regulator that coordinates medicine safety in the UAE, warned against taking dietary supplements, herbal remedies and products sold for weight loss or sports performance alongside prescription medicines without first asking a doctor or pharmacist. In statements to the newspaper Emarat Al Youm, reported in English by Gulf News on November 20, it named two herbs: ginkgo, which may increase the risk of bleeding with some anticoagulants, and St. John's wort, which can make some medicines less effective by changing how the body breaks them down.
Short answer: the evidence is not equal across supplements. St. John's wort is one of the best-documented problem products, with human studies showing it lowers the levels of many medicines, including the contraceptive pill. The ginkgo and warfarin story is more mixed. Several interactions on NHS and FDA lists involve everyday products: vitamin K with warfarin, calcium and iron with levothyroxine, and biotin with blood tests. The US National Center for Complementary and Integrative Health (NCCIH) says most herb-drug interactions listed in current sources are hypothetical, inferred from animal or cell studies, but that attention is needed for medicines with a narrow therapeutic index, such as cancer chemotherapy drugs, warfarin and digoxin.
What the UAE regulator said
- Ginkgo may increase the risk of bleeding when taken with certain anticoagulant medicines.
- St. John's wort can reduce the effectiveness of some medicines by changing how they are metabolized.
- Some products promoted for weight loss or physical performance may contain undisclosed pharmaceutical ingredients, which adds risk, especially at high doses or with other medicines.
- A label saying natural, herbal, supplement or sports product does not establish its safety or regulatory status.
- Do not stop prescribed treatment for a chronic condition suddenly without medical advice. Some epilepsy medicines and corticosteroids may need to be reduced gradually under medical supervision.
- Tell your doctor or pharmacist about everything you take, including vitamins, herbal products, protein powders and sports supplements. If you get unusual symptoms, keep the packaging and note the dose and when you took it, and report suspected reactions through official channels.
St. John's wort: the clearest case
The NCCIH says St. John's wort has an overall high risk of drug interactions because it is a potent inducer of drug-processing enzymes in the cytochrome P450 family and of P-glycoprotein, a transporter in the gut. It says clinically significant interactions have been documented with cyclosporine (a transplant medicine), the HIV medicine indinavir, oral contraceptives, warfarin, digoxin and benzodiazepines, among others.
In a 2003 study in JAMA, 12 healthy volunteers took 300 mg of St. John's wort three times a day for 14 days. Exposure to alprazolam, a medicine broken down by the CYP3A4 enzyme, fell by half and its half-life dropped from an average of 12.4 hours to 6.0 hours. The authors note that CYP3A4 handles at least half of all marketed medicines, so long-term use of the herb may make many medicines less effective or mean higher doses are needed.
A 2003 study of 12 women on a combined contraceptive pill gave them the same dose of St. John's wort for two cycles. The half-life of the estrogen in the pill fell from 23.4 to 12.2 hours, and breakthrough bleeding occurred in 7 of 12 women while they took the herb, against 2 of 12 without it. Levels of the hormones FSH, LH and progesterone did not change significantly, and the authors advised women who take St. John's wort to expect breakthrough bleeding and consider adding a barrier method.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) said in 2014 that it had received 19 Yellow Card reports since 2000 of suspected interactions between St. John's wort and hormonal contraceptives, four involving implants and 15 involving pills. Fifteen ended in unplanned pregnancies. It advises that women using hormonal contraception to prevent pregnancy should not take herbal products containing St. John's wort, which applies to all hormonal methods except intrauterine devices, where there are no data.
Two reports in The Lancet in 2000 showed the stakes. In healthy volunteers, St. John's wort cut exposure to indinavir by an average of 57% and its trough level by 81%, enough, the authors warned, to risk HIV drug resistance and treatment failure. A second report described acute rejection in two heart transplant patients that was put down to an interaction between St. John's wort and cyclosporine.
Epilepsy is another firm no. The MHRA advises that people with epilepsy should not use products containing St. John's wort. After a Yellow Card case in which seizures became more frequent and severe in a patient on levetiracetam, lamotrigine and clobazam, medicines not previously known to interact with it, its expert advisers recommended extending the warnings to all antiepileptic medicines.
The NCCIH's list of medicines that St. John's wort can weaken also includes some antidepressants, the seizure medicines phenytoin and carbamazepine, the heart medicines digoxin and ivabradine, some cancer medicines such as imatinib, and simvastatin. It adds that combining St. John's wort with certain antidepressants or other drugs that affect serotonin may cause serotonin-related side effects, which can be serious. The NHS tells people on warfarin not to take St. John's wort, and lists it among the products that may not mix with levothyroxine.
Ginkgo and blood thinners: a mixed picture
The NCCIH says ginkgo may increase the risk of bleeding in people taking anticoagulants such as warfarin, and that it may interact with other drugs. The US Food and Drug Administration (FDA) says warfarin, ginkgo, aspirin and vitamin E can each thin the blood, and that taking any of them together may increase the potential for internal bleeding or stroke.
The trial evidence is less alarming. In a 2005 crossover study, 12 healthy men took ginkgo for a week before and after a single 25 mg dose of warfarin. Ginkgo did not significantly change the international normalized ratio (INR, the blood-clotting test used to monitor warfarin), platelet aggregation or how the body handled warfarin. A 2011 meta-analysis of 18 randomized trials in 1,985 adults found no significant effect of standardized ginkgo extract on platelet aggregation, fibrinogen or standard clotting times, and concluded that the data did not indicate a higher bleeding risk. Small changes in some subgroups were judged not clinically relevant.
Those studies measured clotting tests rather than bleeding events in people on long-term warfarin, and the 2005 study used healthy men and a single warfarin dose. An analysis of US Veterans Administration medical records published in 2015 found that taking ginkgo with warfarin was associated with a higher risk of a bleeding adverse event than warfarin alone, with a hazard ratio of 1.38 (95% confidence interval 1.20 to 1.58). It is an analysis of records, not a trial. The NCCIH's guidance for health professionals says ginkgo with warfarin is associated with an increased risk of major bleeding events compared with warfarin alone.
Everyday supplements on official interaction lists
- Warfarin: the NHS says do not take St. John's wort or vitamin K supplements, and do not have cranberry juice, cranberry products or grapefruit juice. Foods high in vitamin K, such as broccoli and spinach, can affect how warfarin works; you can still eat them, but the NHS says to talk to your warfarin clinic.
- Levothyroxine: the NHS lists calcium and iron supplements, antacids, St. John's wort and biotin among the products that may not mix with it, biotin because it can affect thyroid tests. It advises taking levothyroxine 30 to 60 minutes before your first meal of the day or any drink with caffeine.
- Biotin and blood tests: the FDA says biotin, often found in dietary supplements, can significantly interfere with certain lab tests and cause incorrect results that may go undetected. It has continued to receive adverse event reports of falsely low troponin results; troponin is one of the markers of heart health measured with tests that use biotin, along with some hormone tests. The FDA says biotin is often found in multivitamins, prenatal vitamins and supplements marketed for hair, skin and nail growth.
- Surgery: the FDA says some supplements can interact harmfully with medicines used before, during or after an operation, and that a health professional may ask you to stop supplements two or three weeks beforehand.
Hidden drugs in weight-loss and sports products
The EDE's warning about weight-loss and performance products is a different problem: the risk comes from medicines that are not on the label. The FDA says many weight-loss products claim to be all natural or herbal, but their ingredients may interact with medications or be dangerous for people with certain medical conditions.
Do not stop a prescribed medicine to make room for a supplement
The EDE's second warning was about stopping treatment. The NHS says not to stop taking prednisolone, a corticosteroid, without talking to a doctor first, because stopping suddenly can cause withdrawal symptoms or make the condition worse, and a doctor may reduce the dose gradually. If a supplement and a medicine may clash, ask the prescriber or a pharmacist what to change rather than stopping the medicine yourself.
Evidence grades
Grades used here describe how well an interaction is shown in people: Strong (human studies or consistent regulator reports agree with a warning), Moderate (a known mechanism plus case reports, with regulators advising against the combination), Limited (few or conflicting human studies) and Insufficient (too little human research to judge).
- St. John's wort lowering levels of other medicines, including the contraceptive pill, cyclosporine and indinavir: Strong. Human pharmacology studies, case reports and regulator warnings agree.
- St. John's wort with epilepsy medicines: Moderate. The interaction is expected from how some antiepileptics are broken down and is supported by Yellow Card reports; the MHRA advises against the combination with all antiepileptics.
- Ginkgo with warfarin and bleeding: Limited. Trials show no change in clotting tests, while one large records analysis found more bleeding events.
- Biotin and incorrect lab results: Strong. The FDA has adverse event reports, including falsely low troponin results.
Our view
- Keep a written list of every supplement, with doses, and show it at every appointment and to the pharmacist when you collect a prescription.
- If you use hormonal contraception, have epilepsy, take warfarin, or take a transplant, HIV, heart or cancer medicine, do not start St. John's wort without checking with the prescriber. UK regulator advice is not to combine it with hormonal contraception or any antiepileptic medicine.
- If you take any blood thinner, ask a pharmacist before using ginkgo or vitamin E supplements alongside it.
- If you take biotin, including in hair, skin and nail products, tell whoever orders your blood tests.
- Treat weight-loss and sports products as a possible source of hidden medicines, and never stop a prescribed medicine on your own to start a supplement.
US rules
In the US, St. John's wort and ginkgo are sold as dietary supplements. The FDA says supplement manufacturers and distributors are responsible for making sure their products are safe before they are marketed, and that the FDA does not review supplements for effectiveness before they reach the market, as it does for medicines. It advises talking with a health care professional before taking any supplement, bringing a list of all supplements and medicines with doses to every visit, and mentioning any pregnancy, breastfeeding, recent illness or surgery. Report a problem with a medicine through the FDA's MedWatch program.
FAQ
Which supplement interacts with the contraceptive pill?
St. John's wort. It speeds up the breakdown of the hormones in the pill and has been linked to breakthrough bleeding and unplanned pregnancies. The MHRA advises women using hormonal contraception to prevent pregnancy not to take it, including with implants.
Is it safe to take ginkgo with warfarin or aspirin?
It is uncertain. Trials found no change in clotting tests, but a large records analysis linked ginkgo with warfarin to more bleeding events, and the NCCIH and FDA both warn about the combination. Ask the doctor or pharmacist who manages your blood thinner before taking it.
Can vitamins interact with medicines?
Yes. The NHS says people on warfarin should not take vitamin K supplements, and lists calcium and iron supplements among the products that may not mix with levothyroxine. Biotin can also distort some blood test results, according to the FDA.
Sources
These are the documents this page relies on.
- Emirates Drug Establishment: ginkgo increases bleeding and St John's wort reduces the effectiveness of medicines (November 17, 2026, in Arabic)Emarat Al Youm
- UAE warns of dangerous interactions between herbal supplements and prescription medicines (November 20, 2026)Gulf News
- Herb-Drug Interactions (NCCIH Clinical Digest for health professionals)National Center for Complementary and Integrative Health (NIH)
- St. John's Wort (last updated May 2025)National Center for Complementary and Integrative Health (NIH)
- Ginkgo (last updated February 2025)National Center for Complementary and Integrative Health (NIH)
- Mixing Medications and Dietary Supplements Can Endanger Your HealthUS Food and Drug Administration
- Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290(11):1500-1504JAMA (PubMed 13129991)
- The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther. 2003;74(6):525-535Clinical Pharmacology & Therapeutics (PubMed 14663455)
- Indinavir concentrations and St John's wort. Lancet. 2000;355(9203):547-548The Lancet (PubMed 10683007)
- Acute heart transplant rejection due to Saint John's wort. Lancet. 2000;355(9203):548-549The Lancet (PubMed 10683008)
- St John's wort: interaction with hormonal contraceptives, including implants (Drug Safety Update, March 2014)Medicines and Healthcare products Regulatory Agency (GOV.UK)
- Herbal ingredient St John's wort may interact with antiepileptics (Drug Safety Update, November 2007)Medicines and Healthcare products Regulatory Agency (GOV.UK)
- Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2005;59(4):425-432British Journal of Clinical Pharmacology (PubMed 15801937)
- Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490-502Pharmacotherapy (PubMed 21923430)
- Ginkgo and warfarin interaction in a large Veterans Administration population. AMIA Annu Symp Proc. 2015;2015:1174-1183AMIA Annual Symposium Proceedings (PubMed 26958257)
- Warfarin (page last reviewed February 24, 2026)NHS
- Levothyroxine (page last reviewed July 6, 2026)NHS
- PrednisoloneNHS
- Biotin Interference with Troponin Lab Tests: Assays Subject to Biotin InterferenceUS Food and Drug Administration
- Testing for Biotin Interference in In Vitro Diagnostic Devices: Guidance for Industry (October 2020)US Food and Drug Administration
- Emirates Drug Establishment launches "Speak Up .. Stay Safe" campaign in collaboration with five health authorities (November 4, 2026)Emirates Drug Establishment (via Zawya)
- MedWatch: the FDA safety information and adverse event reporting programUS Food and Drug Administration